Cryopyrin-associated periodic syndrome historical perspective
Cryopyrin-associated periodic syndrome Microchapters |
Differentiating Cryopyrin-associated periodic syndrome from other Diseases |
---|
Diagnosis |
Treatment |
Case Studies |
Cryopyrin-associated periodic syndrome historical perspective On the Web |
American Roentgen Ray Society Images of Cryopyrin-associated periodic syndrome historical perspective |
FDA on Cryopyrin-associated periodic syndrome historical perspective |
CDC on Cryopyrin-associated periodic syndrome historical perspective |
Cryopyrin-associated periodic syndrome historical perspective in the news |
Blogs on Cryopyrin-associated periodic syndrome historical perspective |
Risk calculators and risk factors for Cryopyrin-associated periodic syndrome historical perspective |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Sahar Memar Montazerin, M.D.[2]
Overview
Historical Perspective
Discovery
- Cryopyrin-associated periodic syndrome was first described by Dr. Hoffman, in 2001, following the identification of the NLRP3 gene as the causative mutant gene in families with Familial cold autoinflammatory syndrome (FCAS) and Muckle-Wells syndrome (MWS).[1]
- The association between [important risk factor/cause] and [disease name] was made in/during [year/event].
- In [year], [scientist] was the first to discover the association between [risk factor] and the development of [disease name].
- In [year], [gene] mutations were first implicated in the pathogenesis of [disease name].
Landmark Events in the Development of Treatment Strategies
Impact on Cultural History
Famous Cases
The following are a few famous cases of [disease name]:
References
- ↑ Hoffman, Hal M.; Mueller, James L.; Broide, David H.; Wanderer, Alan A.; Kolodner, Richard D. (2001). "Mutation of a new gene encoding a putative pyrin-like protein causes familial cold autoinflammatory syndrome and Muckle–Wells syndrome". Nature Genetics. 29 (3): 301–305. doi:10.1038/ng756. ISSN 1061-4036.